Drawing for INNOCAN PHARMA

USPTO serial 88448818

INNOCAN PHARMA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LOBO, DEBORAH E
Law office
TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with INNOCAN PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marc Phillip Bodner

1175 East 27th StreetBROOKLYN, NY 11210UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-itch creams; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations for the treatment of skin irritations, namely, bee stings, sunburn, rashes, sores, corns, calluses, and acne; pharmaceutical preparations for the treatment of back pain; acne medications; pain relief medication; pain relief medication for veterinary purposes; all of the aforementioned goods having a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Apr 1, 2022MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 1, 2022ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 17, 2021GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Sep 17, 2021GNSIINQUIRY TO SUSPENSION E-MAILED—
Sep 17, 2021CNSISUSPENSION INQUIRY WRITTEN—
Sep 10, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 3, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 3, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 3, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 2, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 2, 2021GNSLLETTER OF SUSPENSION E-MAILED—
Feb 2, 2021CNSLSUSPENSION LETTER WRITTEN—
Jan 12, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 12, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 12, 2021ALIEASSIGNED TO LIE—
Jan 8, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 5, 2021DPCCDIVISIONAL PROCESSING COMPLETE—
Dec 17, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 8, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 18, 2020DRRRDIVISIONAL REQUEST RECEIVED—
Nov 18, 2020ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Jun 18, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 16, 2020DOCKASSIGNED TO EXAMINER—
Jan 9, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 9, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 14, 2019DOCKASSIGNED TO EXAMINER—
Jun 12, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 31, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance